References

1. Behin A, Hoang-Xuan K, Carpentier AF, Delattre J-Y (2003) Primary brain tumours in adults. Lancet 361:323-331

2. Grant R (2004) Overview: brain tumour diagnosis and management. Royal College of Physicians guidelines. J Neurol Neurosurg Psychiatry 75 (Suppl 2):18-23

3. Howe FA, Opstad KS (2003) 1H MR spectroscopy of brain tumor and masses. NMR Biomed 16:123-131

4. McKnight TR (2004) Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism. Semin Oncol 31:605-617

5. Li X, Lu Y, Pirzkall A, McKnight T, Nelson SJ (2002) Analysis ofthe spatial characteristics ofmetabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imaging 16:229-237

6. Burtscher IM, Skagerberg G, Geijer B, et al. (2000) Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. Am J Neuroradiol 21:84-93

7. Dowling C, Bollen AW, Noworolski SM, et al. (2001) Preop-erative proton MR spectroscopic imaging ofbrain tumors: correlation with histopathologic analysis of resection specimens. Am J Neuroradiol 22:604-612

8. Croteau D, Scarpace L, Hearshen D, et al. (2001) Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma. Neurosurgery 49:823 - 829

9. Rabinov JD, Lee PL, Barker FG, et al. (2002) In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. Radiology 225:871879

10. Tedeschi G, Lundbom N, Raman R, et al. (1997) Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87:516-524

11. Sener RN (2001) Diffusion MRI: apparent diffusion coefficient (ADC) values in the normal brain and a classification of brain disorders based on ADC values. Comput Med Imaging Graph 25:299-326

12. Kono K, Inoue Y, Nakayama K, et al. (2001) The role of diffusion-weighted imaging in patients with brain tumors. Am J Neuroradiol 22:1081 - 1088

13. Asao C, Korogi Y, Kitajima M, et al. (2005) Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. Am J Neuroradiol 26:1455-1460

14. Muti M, Aprile I, Principi M, et al. (2002) Study on thevari-ations ofthe apparent diffusion coefficient in areas of solid tumor in high grade gliomas. Magn Reson Imaging 20: 635-641

15. Yamasaki F, Kurisu K, Satoh K, et al. (2005) Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 235:985-991

16. Lam WWM, Poon WS, Metreweli C (2002) Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma? Clin Radiol 57: 219-225

17. Tien RD, Felsberg GJ, Friedman H, et al. (1994) MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. Am J Roentgenol 162:671 - 677

18. Cha S, Knopp EA, Johnson G, et al. (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223:11-29

19. Maia ACM, Malheiros SMF, da Rocha AJ, et al. (2005) MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in no-nenhancing gliomas. Am J Neuroradiol 26:777-783

20. Law M, Yang S, Babb JS, et al. (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. Am J Neuroradiol 25:746-755

21. Lev MH, Ozsunar Y, Henson JW, et al. (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. Am JNeuroradiol 25:214-221

22. Cha S, Tihan T, Crawford F, et al. (2005) Differentiation of low-grade oligodendrogliomas from low-grade astrocyto-mas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. Am J Neuroradiol 26:266-273

23. Frayne R, Goodyear BG, Dickhoff P, et al. (2003) Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 38:385-402

24. Di Costanzo A, Trojsi F, Tosetti M, et al. (2003) High-field proton MRS of human brain. Eur J Radiol 48:146-153

25. Counsell CE, Grant R (1998) Incidence studies of primary and secondary intracranial tumours: a systematic review of their methodology and results. J Neurooncol 37:241 -250

26. Prados M (2000) Neoplasms of the central nervous system. In: Bast R, Kufe D, Pollock R, Weichselbaum R, Holland J, Frei E (eds) Cancer medicine, 5th edn. BC Decker, Hamilton, Ontario, pp 1055 -1082

27. Yuh WT, Nguyen HD, Tali ET, et al. (1994) Delineation of gliomas with various doses of MR contrast material. Am J Neuroradiol 15:983 - 989

28. Pirzkall A, McKnight TR, Graves EE, et al. (2001) MR-spec-troscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 50:915-928

29. Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. IARC Press, Lyon, France

30. Fallentin E, Skriver E, Herning M, et al. (1997) Gliomatosis cerebri: an appropriate diagnosis? Case reports. Acta Radiol 38:381-390

31. Barnard RO, Geddes JF (1987) The incidence of multifocal cerebral gliomas: a histologic study of large hemisphere sections. Cancer 60:1519-1531

32. Artigas J, Cervos-Navarro J, Iglesias JR, et al. (1985) Gliomatosis cerebri: clinical and histological findings. Clin Neuropathol 4:135-148

33. Castillo M, Smith JK, Kwock L, Wilber K (2001) Apparent diffusion coefficients in the evaluation ofhigh-grade cerebral gliomas. Am J Neuroradiol 22:60-64

34. LawM, Cha S, Knopp EA, et al. (2002) High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222: 715-721

35. Tzika AA, Astrakas LG, Zarifi MK, et al. (2003) Multipara-metric MR assessment of pediatric brain tumors. Neuroradiology 45:1 -10

36. Chiang IC, Kuo Y-T, Lu C-Y, et al. (2004) Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, andperfusion imagings. Neuroradiology 46:619 -627

37. Strugar JG, Criscuolo GR, Rothbart D, Harrington WN (1995) Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor-associated cysts. J Neu-rosurg 83:682 - 689

38. Cha S, Johnson G, Wadghiri YZ, et al. (2003) Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 49:848855

39. Strugar J, Rothbart D, Harrington W, Criscuolo GR (1994) Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 81:560-566

40. Eis M, Els T, Hoehn-Berlage M (1995) High resolution quantitative relaxation and diffusion MRI of three different experimental brain tumors in rat. Magn Reson Med 34:835-844

41. Black PM (1993) Meningiomas. Neurosurgery32:643-657

42. Mahmood A, Caccamo DV, Tomecek FJ, et al. (1993) Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 33:955-963

43. Maier H, Ofner D, Hittmair A, et al. (1992) Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 77:616-623

44. Nakano T, Asano K, Miura H, et al. (2002) Meningiomas with brain edema. Radiological characteristics on MRI and review of the literature. Clin Imaging 26: 243-249

45. Yang S, Law M, Zagzag D, et al. (2003) Dynamic contrast-enhanced perfusion MR imaging measurements of endo-thelial permeability: differentiation between atypical and typical meningiomas. Am J Neuroradiol 24:1554-1559

46. Cho Y-D, Choi G-H, Lee S-P, Kim J-K (2003) 1H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors. Magn Reson Imaging 21:663-672

47. Provenzale JM, McGraw P, Mhatre P, et al. (2004) Peritu-moral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging. Radiology 232:451 -460

48. Cha S (2004) Perfusion MR imaging of brain tumors. Top Magn Reson Imaging 15:279-289

49. Jellinger KA, Paulus W (1992) Primary central nervous system lymphomas - an update. J Cancer Res Clin Oncol 119:7-27

50. Lai R, Rosenblum MK, DeAngelis LM (2002) Primary CNS lymphoma. A whole-brain disease? Neurology 59:15571562

51. Larocca LM, Capello D, Rinelli A, et al. (1998) The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 92:1011 -1019

52. Buhring U, Herrlinger U, Krings T, et al. (2001) MRI features of primary central nervous system lymphomas at presentation. Neurology 57:393 - 396

53. Küker W, Nägele T, Korfel A, et al. (2005) Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol 72:169-177

54. Hartmann M, Heiland S, Harting I, et al. (2003) Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 338:119 -122

55. Onda K, Wakabayashi K, Tanaka R, Takahashi H (1999) In-tracranial malignant lymphomas: clinicopathological study of 26 autopsy cases. Brain Tumor Pathol 16:29-35

56. Deangelis LM (2001) Brain tumors. N Engl J Med 344:114 -123

57. Jeyapalan S, Batchelor T (2000) Diagnostic evaluation of neurologic metastases. Cancer Invest 18:381 - 394

58. Hwang T, Close T, Grego J, et al. (1996) Predilection of brain metastasis in grey and white matter junction and vascular border zones. Cancer 77:1551 -1555

59. Krabbe K, Gideon P, Wagn P, et al. (1997) MR diffusion imaging of human intracranial tumours. Neuroradiology 39:483-489

60. Kremer S, Grand S, Berger F (2003) Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases. Neuroradiology 45:44-49

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment